Logo image of CLYM

CLIMB BIO INC (CLYM) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CLYM - US28658R1068 - Common Stock

4.29 USD
-0.03 (-0.69%)
Last: 1/21/2026, 8:04:46 PM
4.24 USD
-0.05 (-1.17%)
After Hours: 1/21/2026, 8:04:46 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CLYM revenue by date.CLYM revenue by date.
N/AN/AN/AN/AN/A
140.00%		N/A
281.11%		N/A
195.70%		N/A
145.55%		N/A
77.14%
EBITDA
YoY % growth
CLYM ebitda by date.CLYM ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
-2.20%		N/A
65.14%		N/A
832.19%		N/A
185.43%
EBIT
YoY % growth
CLYM ebit by date.CLYM ebit by date.
-7.45M-20.93M
-180.94%		-35.67M
-70.43%		-45.14M
-26.55%		-21.466M
52.45%		-27.003M
-25.79%		N/A
-141.30%		N/A
-12.16%		N/A
-40.46%		N/A
24.40%		N/A
-26.44%		N/A
-20.58%		N/A
61.12%		N/A
730.15%		N/A
189.80%
Operating Margin
CLYM operating margin by date.CLYM operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CLYM eps by date.CLYM eps by date.
N/AN/AN/A-1.72
73.28%		N/A
22.91%		N/A
-20.77%		N/A
48.13%		N/A
-4.56%		N/A
-26.85%		N/A
-20.37%		N/A
-13.08%		N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.20
-50.39%		-0.21
33.37%		-0.21
-60.85%		-0.22
-14.08%		-0.22
-14.78%		-0.26
-23.46%		-0.27
-26.83%		-0.28
-27.06%		-0.29
-27.27%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-15.595M
-106.47%		-15.453M
32.87%		-15.759M
-47.60%		-16.065M
-7.88%		-16.371M
-4.98%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.19 -0.15-0.04-27.00%
Q2 2025
Q2Q % growth		 -0.13 -0.190.0631.11%
Q1 2025
Q2Q % growth		 -0.31 -0.15-0.16-102.61%
Q4 2024
Q2Q % growth		 -0.13
30.48%		-0.150.0215.03%
Q4 2023
Q2Q % growth
35.52%		-0.19%
Q3 2023
Q2Q % growth
49.46%		-0.19%
Q2 2023
Q2Q % growth
63.57%		-0.20%
Q1 2023
Q2Q % growth		 -0.25
50.00%		-0.260.011.96%
Q4 2022
Q2Q % growth		 -0.29
27.50%		-0.390.1025.18%
Q3 2022
Q2Q % growth		 -0.37
47.14%		-0.440.0716.13%
Q2 2022
Q2Q % growth		 -0.56
81.99%		-0.48-0.08-17.65%
Q1 2022
Q2Q % growth		 -0.50 -0.570.0712.98%
Q4 2021
Q2Q % growth		 -0.40 -0.630.2336.75%
Q3 2021
Q2Q % growth		 -0.70 -0.940.2425.67%
Q2 2021
Q2Q % growth		 -3.11 -1.90-1.21-63.49%
CLYM Yearly EPS VS EstimatesCLYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CLYM Yearly Revenue VS EstimatesCLYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -23.66% 0.7% -9.67%
RevenueN/A N/A N/A N/A